Related Experiment Videos
[Clinical study of incidental prostatic carcinoma]
1Department of Urology, Center for Adult Diseases, Osaka.
Hinyokika Kiyo. Acta Urologica Japonica
|February 1, 1991
Summary
Incidental prostatic adenocarcinoma detected during surgery for benign conditions requires careful consideration. Stage A2 tumors show higher progression rates, particularly without treatment, suggesting a need for intervention.
Area of Science:
- Urology
- Oncology
- Pathology
Context:
- Study conducted at the Center for Adult Diseases, Osaka, from 1961 to 1987.
- Analyzed 28 incidental prostatic adenocarcinoma cases.
- Cases detected during procedures for benign prostatic hypertrophy or bladder carcinoma.
Purpose:
- To evaluate the progression and survival rates of incidental prostatic adenocarcinoma.
- To determine the clinical significance of different stages (A1 and A2) and tumor differentiation.
- To assess the impact of treatment on tumor progression.
Summary:
- Nine cases were Stage A1 and 19 were Stage A2.
- Five Stage A2 and one Stage A1 tumors progressed to clinical carcinoma.
- Survival rates at 5 and 10 years were 75% for A1 and 80%/37% for A2, respectively.
- Stage A2 tumors, especially untreated ones, progressed more frequently than Stage A1.
Impact:
- Suggests that Stage A2 incidental prostate cancer warrants treatment.
- Highlights the higher risk of progression in untreated Stage A2 tumors.
- Informs clinical decision-making for incidental prostate cancer findings.